The growth inhibitory and apoptotic effects of umbelliprenin in a mouse model of systemic candidiasis
© The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International..
AIMS: Umbelliprenin has shown promising biological activities, including immunoregulatory, anti-inflammatory, and anti-cancer effects. The present study investigated the growth inhibitory and apoptotic effects of umbelliprenin against Candida albicans in a BALB/c mice model of disseminated candidiasis.
METHODS AND RESULTS: First, an antimicrobial assay via microdilution sensitivity test was performed. Then, twenty-five 6-week-old female BALB/c mice (20 ± 12 g) were divided into five groups of five mice, including one control group (no umbelliprenin treatment) and four experimental groups: C. albicans-infected mice treated with umbelliprenin at the doses of 5, 10, 20, and 40 mg kg -1. The brain, lung, kidney, spleen, and liver tissues were examined for fungal infection and histological lesions, and TUNEL staining was performed to assess apoptosis. The β-1, 3-glucan synthase assay was used to evaluate enzymatic activity, and gene expression analysis was also performed to investigate the transcriptional changes of ERG11, CDR1, ALS1, and HWP1 genes. The MIC of umbelliprenin was 1.5 mg mL-1. Our results showed that at the 40 mg kg -1 dose, umbelliprenin was able to eradicate fungal infection in BALB/c mice. The percentage of apoptotic cells in umbelliprenin-treated groups increased in a concentration-dependent manner. Umbelliprenin (40 mg kg -1) also inhibited the expression of β-1, 3-glucan synthase, and the genes involved in antifungal resistance (CDR1 and ERG11), as well as the expression of the genes encoding adhesins (ALS1 and HWP1).
CONCLUSION: Our results showed that umbelliprenin could promote antifungal effects, partly via inducing apoptosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:134 |
|---|---|
| Enthalten in: |
Journal of applied microbiology - 134(2023), 9 vom: 05. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rashidi, Mohsen [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antifungal Agents |
|---|
| Anmerkungen: |
Date Completed 15.09.2023 Date Revised 15.09.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jambio/lxad201 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361675577 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361675577 | ||
| 003 | DE-627 | ||
| 005 | 20231226085637.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jambio/lxad201 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1205.xml |
| 035 | |a (DE-627)NLM361675577 | ||
| 035 | |a (NLM)37669891 | ||
| 035 | |a (PII)lxad201 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rashidi, Mohsen |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The growth inhibitory and apoptotic effects of umbelliprenin in a mouse model of systemic candidiasis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.09.2023 | ||
| 500 | |a Date Revised 15.09.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Applied Microbiology International. | ||
| 520 | |a AIMS: Umbelliprenin has shown promising biological activities, including immunoregulatory, anti-inflammatory, and anti-cancer effects. The present study investigated the growth inhibitory and apoptotic effects of umbelliprenin against Candida albicans in a BALB/c mice model of disseminated candidiasis | ||
| 520 | |a METHODS AND RESULTS: First, an antimicrobial assay via microdilution sensitivity test was performed. Then, twenty-five 6-week-old female BALB/c mice (20 ± 12 g) were divided into five groups of five mice, including one control group (no umbelliprenin treatment) and four experimental groups: C. albicans-infected mice treated with umbelliprenin at the doses of 5, 10, 20, and 40 mg kg -1. The brain, lung, kidney, spleen, and liver tissues were examined for fungal infection and histological lesions, and TUNEL staining was performed to assess apoptosis. The β-1, 3-glucan synthase assay was used to evaluate enzymatic activity, and gene expression analysis was also performed to investigate the transcriptional changes of ERG11, CDR1, ALS1, and HWP1 genes. The MIC of umbelliprenin was 1.5 mg mL-1. Our results showed that at the 40 mg kg -1 dose, umbelliprenin was able to eradicate fungal infection in BALB/c mice. The percentage of apoptotic cells in umbelliprenin-treated groups increased in a concentration-dependent manner. Umbelliprenin (40 mg kg -1) also inhibited the expression of β-1, 3-glucan synthase, and the genes involved in antifungal resistance (CDR1 and ERG11), as well as the expression of the genes encoding adhesins (ALS1 and HWP1) | ||
| 520 | |a CONCLUSION: Our results showed that umbelliprenin could promote antifungal effects, partly via inducing apoptosis | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Candida albicans | |
| 650 | 4 | |a apoptosis | |
| 650 | 4 | |a candidiasis | |
| 650 | 4 | |a umbelliprenin | |
| 650 | 7 | |a Antifungal Agents |2 NLM | |
| 700 | 1 | |a Bazi, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadzadeh, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Romeo, Orazio |e verfasserin |4 aut | |
| 700 | 1 | |a Rezaei-Matehkolaei, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Abastabar, Mahdi |e verfasserin |4 aut | |
| 700 | 1 | |a Haghani, Iman |e verfasserin |4 aut | |
| 700 | 1 | |a Mirzaei, Sepideh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of applied microbiology |d 1997 |g 134(2023), 9 vom: 05. Sept. |w (DE-627)NLM090698444 |x 1365-2672 |7 nnns |
| 773 | 1 | 8 | |g volume:134 |g year:2023 |g number:9 |g day:05 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jambio/lxad201 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 134 |j 2023 |e 9 |b 05 |c 09 | ||